Bone cement is commonly known as polymethylmethacrylate (PMMA) and is widely used for implant fixation in various orthopedic, dental, and trauma surgeries. Bone cement has no intrinsic adhesive properties; however, it relies on close mechanical interlock between the irregular bone surface and the prosthesis. Commercially, bone cement is available as calcium phosphate cement (CPC) and glass polyalkenoate (ionomer) cement (GPC). CPC is bioabsorbable and biocompatible, used primarily in cranial and maxillofacial surgeries due to its low mechanical strength. The use of various bone cements have evolved over the past century. Research to develop clinical applications and reduce the adverse effects associated with its use in surgery still continues.
High prevalence of osteoporosis is a major factor driving the global bone cement market. Rise in incidence of periodontics among young adults, growing demand for orthopedic bone cement and casting materials, especially among the geriatric population are few other factors that are anticipated to drive the bone cement market. Increasing number of domestic and global players entering the market with new ingredients such as antibiotic-impregnated bone cement has significantly increased its use in pathological fractures and general prosthetic fixation. According to the World Health Organization, the global population aged 85 years and above will increase by 351% during the next 40 years. Springer Nature’s Osteoporosis International journal published that around 158 million people aged 50 years and above are prone to developing bone fractures. The research further stated that bone fractures could double by 2040. However, some factors such as preference for bone graft over bone cement products in major orthopedic surgeries and local inflammation resulting in chronic complications in hip replacements can restrain the market during the forecast period.
The global bone cement market can be segmented based on product type, application, end-user, and regions. In terms of product type, the bone cement market can be segmented into powder and liquid cement. Liquid bone cement is categorized into monomer, accelerator, and stabilizer. In terms of application, the market can be segmented into orthopedic and dental. The orthopedic segment accounted for a prominent share of the global market in 2016. Increasing prevalence of knee surgeries and rising sports related injuries, especially in emerging economies such as China, Brazil, and India contributed to the expansion of the segment. In terms of end-user, the market can be segmented into hospitals, orthopedic clinics, dental clinics, aesthetics, ambulatory care centers, and others.
Based on regions, the global bone cement market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to dominate the market during the forecast period. According to Centers for Disease Control and Prevention report, an estimated 3.5 Mn to 4.4 Mn people visiting the emergency department are diagnosed with fractures every year. Healthcare costs associated with the treatment of osteoporotic fractures range between US$ 17 Mn and US$ 20 Bn, annually. Furthermore, increasing prevalence of arthritis and periodontal diseases, especially in developing countries such as China and India has led to increase in demand for orthopedic and dental surgeries. According to the International Osteoporosis Foundation, report published in 2017 estimates nearly 8.9 million fractures that occur every year are attributed to osteoporosis. The disease affected more than 75 million people in Europe, U.S., and Japan. Knee surgeries, general prosthetic fixation, and dental diseases have increased in Asia Pacific. This is anticipated to fuel the demand for cost-effective surgeries, which is projected to drive the bone cement market in Asia Pacific during the forecast period.
Key players operating in the global bone cement market include Heraeus Holding, DJO Global, Stryker, Zimmer Biomet, TEKNIMED, Smith & Nephew, 3M, Exactech, Inc., DePuy Synthes Companies, Orthofix International N.V., and BSN medical GmbH.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.